A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.

Affiliation

Huang Q(#)(1), Ji K(#)(1)(2), Tian S(#)(1)(2), Wang F(#)(1)(2), Huang B(3), Tong Z(4)(5), Tan S(4), Hao J(6), Wang Q(1)(4), Tan W(7), Gao GF(8)(9)(10), Yan J(11)(12)(13).
Author information:
(1)CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
(2)University of Chinese Academy of Sciences, Beijing, China.
(3)MHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China.
(4)CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
(5)Shanxi Academy of Advanced Research and Innovation, Taiyuan, China.
(6)Core Facility for Protein Research, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
(7)MHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China. [Email]
(8)University of Chinese Academy of Sciences, Beijing, China. [Email]
(9)CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. [Email]
(10)Chinese Center for Disease Control and Prevention
(China CDC), Beijing, China. [Email]
(11)CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. [Email]
(12)University of Chinese Academy of Sciences, Beijing, China. [Email]
(13)CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. [Email]
(#)Contributed equally

Abstract

Erratum in Nat Commun. 2021 Apr 15;12(1):2355.